| Date Filed | Type | Description |
| 06/02/2023 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 15,151 shares
@ $0
Sold 8,638 shares
@ $23.01, valued at
$198.8k
|
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.|
Txns:
| Granted 30,000 options to buy
@ $2.26, valued at
$67.8k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.|
Txns:
| Granted 22,500 options to buy
@ $1.32, valued at
$29.7k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 15,889 shares
@ $0 |
|
| 11/18/2020 |
3
| SPIEGELMAN DANIEL K (Director) has filed a Form 3 on Jiya Acquisition Corp. |
| 10/08/2020 |
3
| SPIEGELMAN DANIEL K (Director) has filed a Form 3 on SPRUCE BIOSCIENCES, INC. |
| 05/28/2020 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 20,562 shares
@ $0 |
|
| 05/28/2020 |
3
| SPIEGELMAN DANIEL K (Director) has filed a Form 3 on MYRIAD GENETICS INC |
| 06/07/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 176 shares
@ $68.782, valued at
$12.1k
|
|
| 04/03/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 13,473 shares
@ $89, valued at
$1.2M
|
|
| 03/29/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 100 shares
@ $90, valued at
$9k
|
|
| 03/26/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 3,598 shares
@ $88.05, valued at
$316.8k
|
|
| 03/19/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 7,227 shares
@ $94.53, valued at
$683.2k
Granted 9,370 shares
@ $0
Granted 23,450 options to buy
@ $94.53, valued at
$2.2M
|
|
| 03/05/2019 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 12,205 shares
@ $0
Paid exercise price by delivering 912 shares
@ $94.76, valued at
$86.4k
|
|
| 12/20/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 175 shares
@ $68.782, valued at
$12k
|
|
| 06/26/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 9,528 shares
@ $99, valued at
$943.3k
Sold 472 shares
@ $99.01, valued at
$46.7k
|
|
| 06/06/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 167 shares
@ $68.782, valued at
$11.5k
Paid exercise price by delivering 1,711 shares
@ $92.07, valued at
$157.5k
|
|
| 04/27/2018 |
4/A
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 3,598 shares
@ $81.36, valued at
$292.7k
|
|
| 04/26/2018 |
4/A
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 12,615 shares
@ $0 |
|
| 04/25/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Sold 11,059 shares
@ $82.15, valued at
$908.5k
|
|
| 03/26/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 3,583 shares
@ $81.36, valued at
$291.5k
|
|
| 03/19/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 3,815 shares
@ $83.57, valued at
$318.8k
Granted 12,480 shares
@ $0
Granted 39,900 options to buy
@ $83.57, valued at
$3.3M
|
|
| 03/13/2018 |
4
| SPIEGELMAN DANIEL K (Director) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 21,006 shares
@ $0
Disposed/sold 13,927 restricted stock units
@ $0 |
|
| 03/06/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Paid exercise price by delivering 1,609 shares
@ $79.86, valued at
$128.5k
|
|
| 02/28/2018 |
4
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC|
Txns:
| Granted 12,529 shares
@ $0 |
|
| 02/14/2018 |
5
| SPIEGELMAN DANIEL K (EVP, CFO) has filed a Form 5 on BIOMARIN PHARMACEUTICAL INC |
|